Replicative senescence and potential malignant transformation are great limitations in the clinical application of bone marrow-derived mesenchymal stem / stromal cells (MSCs). An abnormal DNA damage response may result in genomic instability, which is an integral component of aging and tumorigenesis. | The replicative senescent mesenchymal stem / stromal cells defect in DNA damage response and anti-oxidative capacity